Literature DB >> 27571523

Ten-Year Follow-up on Tumor Growth and Hearing in Patients Observed With an Intracanalicular Vestibular Schwannoma.

Malene Kirchmann1, Kirstine Karnov1, Søren Hansen1, Thomas Dethloff1, Sven-Eric Stangerup1, Per Caye-Thomasen1,2.   

Abstract

BACKGROUND: Reports on the natural history of tumor growth and hearing in patients with a vestibular schwannoma (VS) are almost exclusively short-term data. Long-term data are needed for comparison with results of surgery and radiotherapy.
OBJECTIVE: To report the long-term occurrence of tumor growth and hearing loss in 156 patients diagnosed with an intracanalicular VS and managed conservatively.
METHODS: In this longitudinal cohort study, diagnostic and follow-up magnetic resonance imaging and audiometry were compared.
RESULTS: After a follow-up of 9.5 years, tumor growth had occurred in 37% and growth into the cerebellopontine angle had occurred in 23% of patients. Conservative treatment failed in 15%. The pure tone average had increased from 51- to 72-dB hearing level, and the speech discrimination score (SDS) had decreased from 60% to 34%. The number of patients with good hearing (SDS > 70%) was reduced from 52% to 22%, and the number of patients with American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) class A hearing was reduced from 19% to 3%. Hearing was preserved better in patients with 100% SDS at diagnosis than in patients with even a small loss of SDS. Serviceable hearing was preserved in 34% according to AAO-HNS (class A-B) and in 58% according to the word recognition score (class I-II). Rate of hearing loss was higher in patients with growing tumors.
CONCLUSION: Tumor growth occurred in only a minority of patients diagnosed with an intracanalicular VS during 10 years of observation. The risk of hearing loss is small in patients with normal discrimination at diagnosis. Serviceable hearing is preserved spontaneously in 34% according to AAO-HNS and in 58% according to the word recognition score.
Copyright © 2016 by the Congress of Neurological Surgeons

Entities:  

Keywords:  Acoustic neuroma; Conservative management; Hearing loss

Mesh:

Year:  2017        PMID: 27571523     DOI: 10.1227/NEU.0000000000001414

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  15 in total

1.  Systematic Review of Hearing Preservation in Observed Vestibular Schwannoma.

Authors:  Martin Reznitsky; Per Cayé-Thomasen
Journal:  J Neurol Surg B Skull Base       Date:  2019-03-01

2.  Long-term hearing outcomes after gamma knife surgery in patients with vestibular schwannoma with hearing preservation: evaluation in 92 patients with serial audiograms.

Authors:  Toshinori Hasegawa; Takenori Kato; Takashi Yamamoto; Takehiro Naito; Naoki Kato; Jun Torii; Kazuki Ishii
Journal:  J Neurooncol       Date:  2018-04-17       Impact factor: 4.130

3.  Vestibular Schwannoma Tumor Size and Growth Rate Predict Response with Gamma Knife Stereotactic Radiosurgery.

Authors:  Daniel E Killeen; Anthony M Tolisano; Brandon Isaacson; J Walter Kutz; Samuel Barnett; Zabi Wardak; Jacob B Hunter
Journal:  J Neurol Surg B Skull Base       Date:  2020-10-05

4.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

5.  Useful hearing preservation is improved in vestibular schwannoma patients who undergo stereotactic radiosurgery before further hearing deterioration ensues.

Authors:  Akiyoshi Ogino; Hao Long; Stephen Johnson; Andrew Faramand; Ajay Niranjan; John C Flickinger; L Dade Lunsford; Hideyuki Kano
Journal:  J Neurooncol       Date:  2021-03-17       Impact factor: 4.130

6.  [Cochlear nerve continuity preservation during retrosigmoid ablative osteotomy of the internal auditory canal for advanced vestibular schwannomas].

Authors:  Katharina Schaumann; A Albrecht; B Turowski; C Hoffmann; J F Cornelius; J Schipper
Journal:  HNO       Date:  2021-11-23       Impact factor: 1.330

7.  The proteome of perilymph in patients with vestibular schwannoma. A possibility to identify biomarkers for tumor associated hearing loss?

Authors:  Jesper Edvardsson Rasmussen; Göran Laurell; Helge Rask-Andersen; Jonas Bergquist; Per Olof Eriksson
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

8.  Multi-option therapy vs observation for small acoustic neuroma: hearing-focused management.

Authors:  E Zanoletti; D Cazzador; C Faccioli; S Gallo; L Denaro; D D'Avella; A Martini; A Mazzoni
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-08       Impact factor: 2.124

9.  The natural history of incidental retroperitoneal schwannomas.

Authors:  Akira Ogose; Hiroyuki Kawashima; Hiroshi Hatano; Takashi Ariizumi; Taro Sasaki; Tetsuro Yamagishi; Naoki Oike; Syoichi Inagawa; Naoto Endo
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

10.  Development of a model to predict vestibular schwannoma growth: An opportunity to introduce new wait and scan strategies.

Authors:  Mayke A Hentschel; Gerjon Hannink; Stefan C A Steens; Jef J S Mulder; Maroeska M Rovers; Henricus P M Kunst
Journal:  Clin Otolaryngol       Date:  2020-11-06       Impact factor: 2.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.